Astellas’ Yoshitsugu Shitaka Elected as New FIRM Chair

June 20, 2023
The Forum for Innovative Regenerative Medicine (FIRM) on June 19 elected Yoshitsugu Shitaka, chief scientific officer at Astellas Pharma, as its new representative director and chairperson. The term of office will be for two years. Mr Shitaka, previously representative director...read more